Author: Admin

MOBILE, Ala., Oct. 24, 2025 /PRNewswire/ — AltaPointe Health, in partnership with MyCare Technologies, the Mobile Police Department, and Mobile Fire-Rescue, has launched a new pilot program aimed at reducing non-emergency 911 calls and improving access to behavioral healthcare for individuals in crisis. For the past few years, Mobile police officers have used iPads in the field to connect individuals experiencing behavioral health crises directly with AltaPointe clinicians. Now, through this new initiative, those same iPads will be placed directly into the hands of frequent 911 callers — giving them immediate, 24/7 access to mental health support from trained professionals.…

Read More

The Dodgers’ pitching staff looked like a buzz saw all postseason, until Toronto broke the machinery. The Blue Jays’ offense did what others could not this October, getting to a Dodgers starter and continuing on with a power display like few others in the history of the Fall Classic as a nine-run inning propelled them to an 11-4 win in Game 1 of the World Series. Here are my takeaways: 1. Blue Jays show blueprint against Dodgers’ rotation (Photo by Mark Blinch/Getty Images) They don’t whiff or strike out, and for those reasons, the Blue Jays’ offense drew some comparisons to a Brewers…

Read More

The Toronto Blue Jays’ quest to break their 32-year title drought started off on the right foot.  Their bats stayed hot, and powered them to an 11-4 win over the Los Angeles Dodgers in Game 1 of the 2025 World Series. Toronto’s win came on the back of a nine-run sixth inning. Addison Barger’s pinch-hit grand slam in that frame broke the game wide open and Alejandro Kirk added a two-run shot for cushion. Shohei Ohtani hit a home run in the seventh, but it was too little too late as the Blue Jays ran away with this one.  Here…

Read More

-Ribo obtiene la designación de fármaco huérfano de la EMA para el siRNA terapéutico RBD1016 para la infección por el virus de la hepatitis delta (VHD) BEIJING y GOTHEMBURGO, Suecia, 24 de octubre de 2025 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. y Ribocure Pharmaceuticals AB (Ribo), anunciaron hoy que la Agencia Europea de Medicamentos (EMA) ha otorgado la Designación de Medicamento Huérfano (ODD) a RBD1016 para el tratamiento de la infección por el Virus de la Hepatitis D (VHD). La designación ODD de la EMA se asigna a terapias en investigación para enfermedades raras potencialmente mortales o crónicamente debilitantes que…

Read More